Search

Your search keyword '"Horneff Gerd"' showing total 1,208 results

Search Constraints

Start Over You searched for: Author "Horneff Gerd" Remove constraint Author: "Horneff Gerd"
1,208 results on '"Horneff Gerd"'

Search Results

1. Summary of Research: Ten-Year Safety and Clinical Benefit from Open-Label Etanercept Treatment in Children and Young Adults with Juvenile Idiopathic Arthritis

3. Physical (in)activity and screen-based media use of adolescents with juvenile idiopathic arthritis over time - data from a German inception cohort

4. Level and correlates of physical activity among children and adolescents with juvenile idiopathic arthritis compared to controls: results from a German nationwide prospective observational cohort study

5. Outbreak of severe community-acquired bacterial infections among children in North Rhine-Westphalia (Germany), October to December 2022

8. German evidence- and consensus-based guidelines 2011 for the treatment of juvenile idiopathic arthritis (JIA)

12. A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS.

14. Adherence, helpfulness and barriers to treatment in juvenile idiopathic arthritis – data from a German Inception cohort

15. Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases

16. Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial

20. Long‐Term Maintenance of Clinical Responses by Individual Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis Treated With Abatacept

21. Effect of Characteristic Inflammatory and Structural Pelvic Magnetic Resonance Imaging Lesions on Expert Assessment of Axial Juvenile Spondyloarthritis.

25. A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

26. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations

30. Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial

34. Episodische Fiebersyndrome – autoinflammatorische Syndrome

35. Juvenile idiopathische Arthritis

36. Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis.

37. Inflammatory biomarker analysis confirms reduced disease severity in heterozygous patients with familial Mediterranean fever.

38. Differences Sustained Between Diffuse and Limited Forms of Juvenile Systemic Sclerosis in an Expanded International Cohort

41. Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study

42. Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

43. S2k guideline: Diagnosis and therapy of localized scleroderma

44. Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry

45. Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registry

47. Experiences with IL-1 blockade in systemic juvenile idiopathic arthritis – data from the German AID-registry

48. Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial

49. Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis.

Catalog

Books, media, physical & digital resources